Skip to main content
Caplight Logo









Upstream Biotechnology, Inc.

Upstream Biotechnology, Inc.

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.upstreambiotech.com/

Last Round

Seed

Jul 28, 2026

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Upstream Biotechnology, Inc. is an agricultural biotechnology company that develops programmable translational control technologies and seed traits to enhance crop disease resistance and resilience.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

agricultural biotechnologyagtechgene regulationcrop resilienceSwitchBladetranslational controlRNA-based technologyplant immunitygene expressioncrop traitmolecular biologyyield stabilitybiotech licensingseed technologygenomic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Upstream Biotechnology, Inc. Comparables

Compare Upstream Biotechnology, Inc. with similar companies based on industry and business-model similarity.

Upstream Biotechnology, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GeneNeer
78%
Terrana Biosciences
77%
AgriRNA Biosciences
76%

Upstream Biotechnology, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 28, 2026
SeedJul 28, 2026

Key People

Founding team and executive leadership

George Greene

Chief Executive Officer

Executive Team

Upstream Biotechnology, Inc. Investors

Notable investors and investment history

Upstream Biotechnology, Inc. investors
InvestorRounds
LeVert VenturesSeed
Corteva CatalystSeed
SilverBlueSeed
VTC VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Led by LeVert Ventures with participation from VTC Ventures and Corteva Catalyst.

  • Jul 28, 2026

    Led by LeVert Ventures with participation from VTC Ventures and Corteva Agriscience.

Upstream Biotechnology, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Upstream Biotechnology, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Upstream Biotechnology, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range9
Year FoundedN/A
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?